Dexmedetomidine and esketamine given around surgery to improve recovery after general anesthesia
Official title: Impact of Perioperative Dexmedetomidine and Esketamine on Postoperative Quality of Recovery in Patients Undergoing General Anesthesia and Surgery: A 2×2 Factorial Randomized Trial
Run by Peking University First Hospital · NCT07308756 · Data updated 2026-11-12
This trial will test whether giving dexmedetomidine, esketamine, or both during the perioperative period helps adults recover better after surgery under general anesthesia.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 316 (estimated) |
| Sponsor | Peking University First Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | January 5, 2026 |
| Main results expected | March 2027 |
| Study ends | April 2027 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT07308756 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older scheduled for at least one-hour surgery under general anesthesia who will receive postoperative patient-controlled intravenous analgesia and can communicate preoperatively.
✕Probably not a fit
Patients with severe bradycardia or conduction blocks, significant liver or renal failure, intracranial tumors or neurosurgery, certain psychiatric or neurologic disorders, or those not requiring postoperative PCA are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, phase 4, randomized 2x2 factorial trial at Peking University First Hospital assigning adults undergoing general anesthesia to receive dexmedetomidine, esketamine, both, or placebo during the perioperative period. The primary outcome is patient-reported quality of recovery (QoR), a multidimensional measure including pain, sleep quality, cognitive function, and emotional stability, with additional measures such as opioid consumption and adverse events. Eligible participants are adults scheduled for surgeries of at least one hour who will use postoperative patient-controlled intravenous analgesia, while patients with significant cardiac conduction disease, severe organ dysfunction, intracranial disease, or certain neuropsychiatric disorders are excluded. The trial compares the independent and combined effects of the two drugs to see if either or both improve overall postoperative recovery.
Why it matters
Potential benefit: If successful, this could reduce postoperative pain and opioid use, improve sleep and overall recovery, and shorten hospital stays for surgical patients.
How similar studies have gone: Previous studies show perioperative dexmedetomidine or ketamine/esketamine can improve analgesia and sleep, but combining the two and measuring patient-reported quality of recovery is less well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18 years or over; * Scheduled to undergo surgery under general anesthesia, with an expected surgical duration of at least 1 hour; * Required patient-controlled intravenous analgesia after surgery. Exclusion Criteria: * Unable to communicate preoperatively due to visual, auditory, or verbal barriers or other reasons; * Severe bradycardia (heart rate \<50 bpm), sick sinus syndrome, or grade 2 or higher atrioventricular block without pacemaker; * History of hyperthyroidism or pheochromocytoma; * History of schizophrenia, epilepsy, Parkinson's disease, myasthenia gravis, or intracranial hypertension; * Intracranial tumor or neurosurgery; * Severe liver dysfunction (Child-Pugh class C), renal failure (requiring renal replacement therapy), or American Society of Anesthesiologists class IV or higher; * Enrolled in other clinical studies.
Where it's running
-
Peking University First Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Principal investigator: Dong-Xin Wang, MD, PhD — Peking University First Hospital
- Study coordinator: Dong-Xin Wang, MD, PhD
- Email: wangdongxin@hotmail.com
- Phone: 8610 83572784
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dexmedetomidine vs magnesium with lidocaine for eye block during DCR surgery
This trial tests whether adding dexmedetomidine or magnesium sulfate to lidocaine for a preemptive peribulbar block can better manage blood pressure and heart rate in adults undergoing DCR surgery under general anesthesia.
-
Hyperangulated vs. Macintosh blades for obstetric intubation
This study tests whether a hyperangulated blade or a Macintosh-style blade helps obstetric patients get an endotracheal tube placement more safely during cesarean deliveries under general anesthesia.
-
Intranasal dexmedetomidine‑esketamine for pain relief after adenoid and tonsil surgery in children
This trial will test whether giving children aged 3–7 a combined dexmedetomidine and esketamine nasal dose reduces pain after adenoid and tonsil surgery.
-
Remimazolam, dexmedetomidine, or esketamine to calm young children before surgery
This trial will test which of three drugs—remimazolam, dexmedetomidine, or esketamine—best calms children aged 2–5 before adenotonsillectomy and reduces postoperative agitation.
-
Comparing dexmedetomidine and lidocaine for pain management after mastectomy
This study is testing whether dexmedetomidine or lidocaine works better for managing pain after mastectomy surgery in adults aged 18 to 75.
-
Combining dexmedetomidine and esketamine to improve sleep after major surgery
This study is testing whether a mix of two medications, dexmedetomidine and esketamine, can help adults sleep better after major surgery compared to a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.